BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Doxorubicin, rs3825942, PDX1, nitric oxide metabolic process, HIV infection, Pancreas)
Bookmark Forward

QuickView for INPP4B (gene)


Body Atlas

Most Correlated Tissues

  1. Transverse colon
  2. Cerebellum
  3. Cerebellar vermis
  4. Cerebral cortex
  5. Ventral tegmental area
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Shock
  2. Disease due to Neisseria
  3. Bacteremia
  4. Viremia
  5. Listeriosis
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. NOC 18
  2. nitidine chloride
  3. irinotecan
  4. Ethacrynic Acid
  5. glargine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. NCOR1
  2. POU3F1
  3. LYL1
  4. BAG1
  5. PIK3CG
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer.
  2. Ese-3 contributes to colon cancer progression by downregulating EHD2 and transactivating INPP4B.
  3. lncRNA RAET1K Promotes the Progression of Acute Myeloid Leukemia by Targeting miR-503-5p/INPP4B Axis…
  4. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.
  5. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Lepto…
  2. Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Ca…
  3. Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
  4. Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast C…
Explore Clinical Trials Results
  • Copyright © 2021 Illumina Inc. All rights reserved.